StockData
Allarity Therapeutics, Inc. logo

Allarity Therapeutics, Inc. (ALLR) stock

ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.84−0.03 (-3.91%)

Close on Nov 17, 2026Market cap $13.38MP/E –Yield –

Allarity Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Allarity Therapeutics's price to book ratio was 4.2× on Nov 11, 2026, against 1.8× a year earlier. Over the last 2 years it ranged from 0.2× to 9.6×, with a median of 1.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.2×+2.8
2025Dec 31, 20251.4×+1.2
2024Dec 31, 20240.2×–

More Allarity Therapeutics figures

See a number that looks wrong?